286 related articles for article (PubMed ID: 32669844)
1. A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model.
Klapproth AP; Shevtsov M; Stangl S; Li WB; Multhoff G
Int J Nanomedicine; 2020; 15():4677-4689. PubMed ID: 32669844
[TBL] [Abstract][Full Text] [Related]
2. Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs).
Shevtsov M; Nikolaev B; Marchenko Y; Yakovleva L; Skvortsov N; Mazur A; Tolstoy P; Ryzhov V; Multhoff G
Int J Nanomedicine; 2018; 13():1471-1482. PubMed ID: 29559776
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution and Clearance of Stable Superparamagnetic Maghemite Iron Oxide Nanoparticles in Mice Following Intraperitoneal Administration.
Pham BTT; Colvin EK; Pham NTH; Kim BJ; Fuller ES; Moon EA; Barbey R; Yuen S; Rickman BH; Bryce NS; Bickley S; Tanudji M; Jones SK; Howell VM; Hawkett BS
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29320407
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: magnetic targeting.
Mojica Pisciotti ML; Lima E; Vasquez Mansilla M; Tognoli VE; Troiani HE; Pasa AA; Creczynski-Pasa TB; Silva AH; Gurman P; Colombo L; Goya GF; Lamagna A; Zysler RD
J Biomed Mater Res B Appl Biomater; 2014 May; 102(4):860-8. PubMed ID: 24458920
[TBL] [Abstract][Full Text] [Related]
5. Magnetically driven nanoparticles:
De Simone M; Panetta D; Bramanti E; Giordano C; Salvatici MC; Gherardini L; Menciassi A; Burchielli S; Cinti C; Salvadori PA
Contrast Media Mol Imaging; 2016 Nov; 11(6):561-571. PubMed ID: 28052582
[TBL] [Abstract][Full Text] [Related]
6. 99mTc-labeled superparamagnetic iron oxide nanoparticles for multimodality SPECT/MRI of sentinel lymph nodes.
Madru R; Kjellman P; Olsson F; Wingårdh K; Ingvar C; Ståhlberg F; Olsrud J; Lätt J; Fredriksson S; Knutsson L; Strand SE
J Nucl Med; 2012 Mar; 53(3):459-63. PubMed ID: 22323777
[TBL] [Abstract][Full Text] [Related]
7. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
8. Theranostic Application of Mixed Gold and Superparamagnetic Iron Oxide Nanoparticle Micelles in Glioblastoma Multiforme.
Sun L; Joh DY; Al-Zaki A; Stangl M; Murty S; Davis JJ; Baumann BC; Alonso-Basanta M; Kaol GD; Tsourkas A; Dorsey JF
J Biomed Nanotechnol; 2016 Feb; 12(2):347-56. PubMed ID: 27305768
[TBL] [Abstract][Full Text] [Related]
9. Erratum: A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model [Corrigendum].
Int J Nanomedicine; 2020; 15():6067. PubMed ID: 32884262
[TBL] [Abstract][Full Text] [Related]
10. Triple Therapy of HER2
Zolata H; Afarideh H; Davani FA
Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
[TBL] [Abstract][Full Text] [Related]
11. Metabolic pathway and distribution of superparamagnetic iron oxide nanoparticles: in vivo study.
Schlachter EK; Widmer HR; Bregy A; Lönnfors-Weitzel T; Vajtai I; Corazza N; Bernau VJ; Weitzel T; Mordasini P; Slotboom J; Herrmann G; Bogni S; Hofmann H; Frenz M; Reinert M
Int J Nanomedicine; 2011; 6():1793-800. PubMed ID: 21980242
[TBL] [Abstract][Full Text] [Related]
12. Preclinical ImmunoPET Imaging of Glioblastoma-Infiltrating Myeloid Cells Using Zirconium-89 Labeled Anti-CD11b Antibody.
Nigam S; McCarl L; Kumar R; Edinger RS; Kurland BF; Anderson CJ; Panigrahy A; Kohanbash G; Edwards WB
Mol Imaging Biol; 2020 Jun; 22(3):685-694. PubMed ID: 31529407
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
Kandasamy G; Maity D
Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
[TBL] [Abstract][Full Text] [Related]
14. Tunable and noncytotoxic PET/SPECT-MRI multimodality imaging probes using colloidally stable ligand-free superparamagnetic iron oxide nanoparticles.
Pham TN; Lengkeek NA; Greguric I; Kim BJ; Pellegrini PA; Bickley SA; Tanudji MR; Jones SK; Hawkett BS; Pham BT
Int J Nanomedicine; 2017; 12():899-909. PubMed ID: 28184160
[TBL] [Abstract][Full Text] [Related]
15. Validation of MRI quantitative susceptibility mapping of superparamagnetic iron oxide nanoparticles for hyperthermia applications in live subjects.
Deh K; Zaman M; Vedvyas Y; Liu Z; Gillen KM; O' Malley P; Bedretdinova D; Nguyen T; Lee R; Spincemaille P; Kim J; Wang Y; Jin MM
Sci Rep; 2020 Jan; 10(1):1171. PubMed ID: 31980695
[TBL] [Abstract][Full Text] [Related]
16. Promoting the Delivery of Nanoparticles to Atherosclerotic Plaques by DNA Coating.
Zhang L; Tian XY; Chan CKW; Bai Q; Cheng CK; Chen FM; Cheung MSH; Yin B; Yang H; Yung WY; Chen Z; Ding F; Leung KC; Zhang C; Huang Y; Lau JYW; Choi CHJ
ACS Appl Mater Interfaces; 2019 Apr; 11(15):13888-13904. PubMed ID: 30516979
[TBL] [Abstract][Full Text] [Related]
17. Characterization of liposome-containing SPIONs conjugated with anti-CD20 developed as a novel theranostic agent for central nervous system lymphoma.
Saesoo S; Sathornsumetee S; Anekwiang P; Treetidnipa C; Thuwajit P; Bunthot S; Maneeprakorn W; Maurizi L; Hofmann H; Rungsardthong RU; Saengkrit N
Colloids Surf B Biointerfaces; 2018 Jan; 161():497-507. PubMed ID: 29128836
[TBL] [Abstract][Full Text] [Related]
18. Superparamagnetic iron-oxide nanoparticles mPEG350- and mPEG2000-coated: cell uptake and biocompatibility evaluation.
Silva AH; Lima E; Mansilla MV; Zysler RD; Troiani H; Pisciotti MLM; Locatelli C; Benech JC; Oddone N; Zoldan VC; Winter E; Pasa AA; Creczynski-Pasa TB
Nanomedicine; 2016 May; 12(4):909-919. PubMed ID: 26767515
[TBL] [Abstract][Full Text] [Related]
19. Quantitative histochemistry for macrophage biodistribution on mice liver and spleen after the administration of a pharmacological-relevant dose of polyacrylic acid-coated iron oxide nanoparticles.
Rodrigues D; Freitas M; Marisa Costa V; Arturo Lopez-Quintela M; Rivas J; Freitas P; Carvalho F; Fernandes E; Silva P
Nanotoxicology; 2017 Mar; 11(2):256-266. PubMed ID: 28166432
[TBL] [Abstract][Full Text] [Related]
20. Toxicity assessment of superparamagnetic iron oxide nanoparticles in different tissues.
Vakili-Ghartavol R; Momtazi-Borojeni AA; Vakili-Ghartavol Z; Aiyelabegan HT; Jaafari MR; Rezayat SM; Arbabi Bidgoli S
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):443-451. PubMed ID: 32024389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]